GLP-1 vs Qsymia for Weight Loss: Which Medication Is Right for You?

If you're exploring prescription weight loss options, you've likely come across two popular choices: GLP-1 medications and Qsymia. Both have proven track records for helping people lose weight, but they work in fundamentally different ways and come with different considerations.

Understanding the key differences between GLP-1 vs Qsymia can help you have a more informed conversation with your healthcare provider about which option might be best for your specific situation.

What Are GLP-1 Medications?

GLP-1 medications include drugs like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro and Zepbound). These medications mimic a natural hormone in your body called glucagon-like peptide-1.

GLP-1 medications work by slowing down how quickly your stomach empties, which helps you feel full longer. They also affect areas of your brain that regulate appetite, reducing hunger and cravings. Additionally, they help regulate blood sugar levels, which is why some GLP-1 medications were originally developed for type 2 diabetes.

These medications are typically administered as a once-weekly injection using a small, pre-filled pen that's relatively easy to use at home.

What Is Qsymia?

Qsymia is a combination medication that contains two active ingredients: phentermine and topiramate. Phentermine is an appetite suppressant that's been used for decades, while topiramate is an anticonvulsant medication that also reduces appetite and helps you feel full.

Unlike GLP-1 medications, Qsymia is taken as a daily oral capsule. The combination of these two drugs works primarily on your central nervous system to decrease hunger and increase feelings of fullness.

Qsymia has been FDA-approved for chronic weight management since 2012 and is typically prescribed for people with a BMI of 30 or higher, or 27 or higher with weight-related health conditions.

Effectiveness: How Much Weight Can You Lose?

Both options have shown significant weight loss results in clinical studies, though the numbers vary.

GLP-1 medications have demonstrated impressive results. Semaglutide studies show an average weight loss of 15-20% of body weight over 68 weeks. Tirzepatide has shown even more dramatic results, with some participants losing up to 20-25% of their body weight.

Qsymia clinical trials have shown an average weight loss of 10-11% of body weight over one year for patients taking the highest recommended dose. While this is less than the average for GLP-1 medications, it's still considered clinically significant weight loss.

Individual results vary widely with both medications, and success depends on many factors including diet, exercise, and adherence to treatment.

Side Effects and Safety Considerations

GLP-1 medications commonly cause gastrointestinal side effects, especially when first starting or increasing doses. These include nausea, vomiting, diarrhea, and constipation. Most people find these effects diminish over time as their body adjusts.

More serious but rare risks include pancreatitis, gallbladder problems, and potential thyroid concerns. GLP-1 medications are not recommended for people with a personal or family history of certain thyroid cancers.

Qsymia's side effects are different. Common ones include tingling in hands and feet, dizziness, altered taste (especially with carbonated beverages), dry mouth, and constipation. Some people also experience sleep problems or difficulty concentrating.

Importantly, Qsymia carries a risk of birth defects and should never be taken during pregnancy. Women of childbearing age must use effective contraception and have negative pregnancy tests before starting and monthly during treatment. Qsymia can also increase heart rate and shouldn't be used by people with certain heart conditions or uncontrolled high blood pressure.

Cost and Accessibility

Cost can be a significant factor when choosing between these medications.

Brand-name GLP-1 medications can be expensive without insurance, sometimes exceeding $1,000 per month. However, compounded versions of Semaglutide and Tirzepatide are available at much lower costs, often starting around $99 per month through telehealth providers.

Qsymia's brand-name version typically costs between $150-200 per month without insurance. Generic versions are not currently available since the brand still holds the patent.

Insurance coverage varies widely for both options. Some plans cover weight loss medications while others don't, or they may require prior authorization and documentation of previous weight loss attempts.

Which One Is Right for You?

The choice between GLP-1 medications and Qsymia depends on several personal factors.

GLP-1 medications might be a better choice if you have type 2 diabetes or prediabetes, prefer weekly injections over daily pills, or if you're looking for potentially greater weight loss results. You can read more about GLP-1 therapy and related topics at ozarihealth.com/blog.

Qsymia might be more suitable if you prefer oral medication, have a lower BMI and need a less intensive option, or if cost is a primary concern and you have insurance coverage for it.

Neither medication is recommended if you're pregnant, planning to become pregnant, or breastfeeding. Both require a prescription and medical supervision.

Key Takeaways

• Different mechanisms: GLP-1 medications mimic natural hormones to reduce appetite and slow digestion, while Qsymia combines two drugs that work on the central nervous system to suppress hunger.
• Weight loss results: GLP-1 medications typically show higher average weight loss (15-25%) compared to Qsymia (10-11%), though individual results vary.
• Administration differs: GLP-1s require weekly injections while Qsymia is a daily oral medication, which may influence your preference.
• Unique considerations: Qsymia has strict pregnancy prevention requirements, while GLP-1s have gastrointestinal side effects that usually improve over time.

Frequently Asked Questions

Can you take GLP-1 medications and Qsymia together?

This is not typically recommended and would require careful evaluation by a healthcare provider. Combining weight loss medications can increase the risk of side effects and complications. Always consult your doctor before taking multiple weight loss medications together.

How long do you need to stay on these medications?

Both GLP-1 medications and Qsymia are intended for long-term use as part of chronic weight management. Most people regain weight when they stop taking these medications, so they're typically continued as long as they're effective and well-tolerated. Your healthcare provider will help determine the appropriate duration for your individual situation.

Do these medications work without diet and exercise?

While both medications can produce weight loss on their own, they work best when combined with lifestyle changes including a reduced-calorie diet and increased physical activity. Think of these medications as tools that make it easier to stick to healthy habits, not replacements for them. The most successful outcomes come from combining medication with sustainable lifestyle modifications.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.